FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1504455503> ?p ?o ?g. }

• W1504455503 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CABackground: Mer tyrosine kinase is frequently overexpressed and activated in non-small cell lung cancer (NSCLC). In addition, genetic inhibition of Mer reduces NSCLC cell growth in vitro and tumor xenograft growth in vivo. In this study, we examined anti-tumor effects mediated by a first-in-class Mer-selective small molecule tyrosine kinase inhibitor (TKI) in pre-clinical models of NSCLC.Methods: The effects of Mer TKI treatment on activation of Mer and related members of the TAM-family of kinases, Axl and Tyro3, and effects on downstream proliferative and pro-survival signaling pathways were analyzed by immunoblot. In addition, Mer TKI-mediated anti-tumor activity was determined in a panel of NSCLC cell lines using soft-agar and clonogenic assays. Cells were stained with YoPro-1-iodide and propidium iodide dyes and induction of apoptosis was determined using flow cytometry. Finally, a subcutaneous murine xenograft model was employed to determine therapeutic effects in vivo.Results: The Mer TKI blocked Mer autophosphorylation in numerous cell lines at sub-micromolar concentrations and was highly selective for Mer over Axl and Tyro3. Treatment also inhibited downstream pro-survival signaling through the ERK1/2 and AKT pathways, which resulted in induction of apoptosis. Additionally, treatment reduced colony-forming potential in soft-agar and clonogenic assays by 85% to 99% in a large panel of cell lines. Sensitivity to the Mer TKI was independent of driver oncogene status, as cell lines positive for EGFR mutations, KRAS mutations, and gene fusions all responded to treatment. Interestingly, RNAi mediated knock-down of Axl enhanced sensitivity to Mer TKI treatment in biochemical and functional assays. Finally, in animals treatment decreased tumor progression resulting in a significant decrease in tumor volume.Conclusions: This Mer TKI is a novel and potent small molecule inhibitor that is selective for Mer over other TAM family kinases in cell-based assays. Treatment with this compound resulted in decreased downstream pro-oncogenic signaling, increased apoptosis, and decreased colony-forming potential in NSCLC cell lines. In addition, treatment was therapeutically effective in murine xenografts. Taken together, these data indicate that Mer inhibition may be an effective strategy for treatment of lung cancer. Sensitivity to the Mer TKI did not depend on driver oncogene status. Development of Mer TKIs for clinical application may therefore provide a molecularly-targeted treatment option for patients without known oncogenic mutations. In addition, Axl inhibition sensitized NSCLC cells to treatment with Mer TKI, suggesting a functional and/or physical interaction between Mer and Axl. In summary, the data presented here validate this Mer TKI as a potential treatment for NSCLC and provide critical data to support its continued development toward clinical application.Citation Format: Christopher T. Cummings, Kurtis D. Davies, Jacqueline Carrico, Deborah DeRyckere, Weihe Zhang, Xiaodong Wang, Stephen Frye, H. Shelton Earp, Douglas K. Graham. Inhibition of Mer tyrosine kinase with a novel small molecule inhibitor is efficacious in pre-clinical models of non-small cell lung cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1742. doi:10.1158/1538-7445.AM2014-1742" @default.
• W1504455503 created "2016-06-24" @default.
• W1504455503 creator A5021975754 @default.
• W1504455503 creator A5025126021 @default.
• W1504455503 creator A5033923298 @default.
• W1504455503 creator A5037575339 @default.
• W1504455503 creator A5037597725 @default.
• W1504455503 creator A5040205022 @default.
• W1504455503 creator A5049715475 @default.
• W1504455503 creator A5085390573 @default.
• W1504455503 creator A5091474668 @default.
• W1504455503 date "2014-09-30" @default.
• W1504455503 modified "2023-09-26" @default.
• W1504455503 title "Abstract 1742: Inhibition of Mer tyrosine kinase with a novel small molecule inhibitor is efficacious in pre-clinical models of non-small cell lung cancer" @default.
• W1504455503 doi "https://doi.org/10.1158/1538-7445.am2014-1742" @default.
• W1504455503 hasPublicationYear "2014" @default.
• W1504455503 type Work @default.
• W1504455503 sameAs 1504455503 @default.
• W1504455503 citedByCount "0" @default.
• W1504455503 crossrefType "proceedings-article" @default.
• W1504455503 hasAuthorship W1504455503A5021975754 @default.
• W1504455503 hasAuthorship W1504455503A5025126021 @default.
• W1504455503 hasAuthorship W1504455503A5033923298 @default.
• W1504455503 hasAuthorship W1504455503A5037575339 @default.
• W1504455503 hasAuthorship W1504455503A5037597725 @default.
• W1504455503 hasAuthorship W1504455503A5040205022 @default.
• W1504455503 hasAuthorship W1504455503A5049715475 @default.
• W1504455503 hasAuthorship W1504455503A5085390573 @default.
• W1504455503 hasAuthorship W1504455503A5091474668 @default.
• W1504455503 hasConcept C101544691 @default.
• W1504455503 hasConcept C117262875 @default.
• W1504455503 hasConcept C121608353 @default.
• W1504455503 hasConcept C126322002 @default.
• W1504455503 hasConcept C150109051 @default.
• W1504455503 hasConcept C184235292 @default.
• W1504455503 hasConcept C190283241 @default.
• W1504455503 hasConcept C2775934118 @default.
• W1504455503 hasConcept C2778820342 @default.
• W1504455503 hasConcept C2781187634 @default.
• W1504455503 hasConcept C31573885 @default.
• W1504455503 hasConcept C42362537 @default.
• W1504455503 hasConcept C502942594 @default.
• W1504455503 hasConcept C526805850 @default.
• W1504455503 hasConcept C55493867 @default.
• W1504455503 hasConcept C62478195 @default.
• W1504455503 hasConcept C71924100 @default.
• W1504455503 hasConcept C75217442 @default.
• W1504455503 hasConcept C86803240 @default.
• W1504455503 hasConcept C95444343 @default.
• W1504455503 hasConcept C97029542 @default.
• W1504455503 hasConceptScore W1504455503C101544691 @default.
• W1504455503 hasConceptScore W1504455503C117262875 @default.
• W1504455503 hasConceptScore W1504455503C121608353 @default.
• W1504455503 hasConceptScore W1504455503C126322002 @default.
• W1504455503 hasConceptScore W1504455503C150109051 @default.
• W1504455503 hasConceptScore W1504455503C184235292 @default.
• W1504455503 hasConceptScore W1504455503C190283241 @default.
• W1504455503 hasConceptScore W1504455503C2775934118 @default.
• W1504455503 hasConceptScore W1504455503C2778820342 @default.
• W1504455503 hasConceptScore W1504455503C2781187634 @default.
• W1504455503 hasConceptScore W1504455503C31573885 @default.
• W1504455503 hasConceptScore W1504455503C42362537 @default.
• W1504455503 hasConceptScore W1504455503C502942594 @default.
• W1504455503 hasConceptScore W1504455503C526805850 @default.
• W1504455503 hasConceptScore W1504455503C55493867 @default.
• W1504455503 hasConceptScore W1504455503C62478195 @default.
• W1504455503 hasConceptScore W1504455503C71924100 @default.
• W1504455503 hasConceptScore W1504455503C75217442 @default.
• W1504455503 hasConceptScore W1504455503C86803240 @default.
• W1504455503 hasConceptScore W1504455503C95444343 @default.
• W1504455503 hasConceptScore W1504455503C97029542 @default.
• W1504455503 hasLocation W15044555031 @default.
• W1504455503 hasOpenAccess W1504455503 @default.
• W1504455503 hasPrimaryLocation W15044555031 @default.
• W1504455503 hasRelatedWork W1519951345 @default.
• W1504455503 hasRelatedWork W1566926127 @default.
• W1504455503 hasRelatedWork W1568480125 @default.
• W1504455503 hasRelatedWork W1833559879 @default.
• W1504455503 hasRelatedWork W1960808995 @default.
• W1504455503 hasRelatedWork W1973723861 @default.
• W1504455503 hasRelatedWork W1979302285 @default.
• W1504455503 hasRelatedWork W1993985222 @default.
• W1504455503 hasRelatedWork W2006584555 @default.
• W1504455503 hasRelatedWork W2051339774 @default.
• W1504455503 hasRelatedWork W2068602661 @default.
• W1504455503 hasRelatedWork W2089667546 @default.
• W1504455503 hasRelatedWork W2161764875 @default.
• W1504455503 hasRelatedWork W2190716655 @default.
• W1504455503 hasRelatedWork W2318589295 @default.
• W1504455503 hasRelatedWork W2559166357 @default.
• W1504455503 hasRelatedWork W2741698088 @default.
• W1504455503 hasRelatedWork W2887204203 @default.
• W1504455503 hasRelatedWork W2887445794 @default.
• W1504455503 hasRelatedWork W3012487685 @default.
• W1504455503 isParatext "false" @default.
• W1504455503 isRetracted "false" @default.
• W1504455503 magId "1504455503" @default.
• W1504455503 workType "article" @default.